Researchers mapping blood-to-brain transport discovered that the blood-brain barrier selectively imports 92 neuroprotective proteins, including liver-derived APOA1, which helps clear brain plaques and improve memory in Alzheimer’s mouse models before the physical barrier begins to leak.
The Blood-Brain Barrier Imports Protective Proteins to Support Memory
- Beyond a Simple Wall: The blood-brain barrier actively selects and imports specific circulating proteins from the body rather than merely acting as an impermeable shield.
- Early Failure: In Alzheimer’s disease models, this vital import machinery fails early, cutting off protective proteins before the barrier starts breaking down.
- Restoring Supply: Boosting liver production of APOA1 successfully restored lipid balance in brain astrocytes and improved spatial memory in mice.
Mapping the Brain Transport System
Scientists from Gladstone Institutes, the University of California, San Francisco, the Buck Institute for Research on Aging, Emory University, and institutions in China published findings in the journal Cell detailing how proteins cross the blood-brain barrier (BBB).
Utilizing a bioorthogonal proteomics approach, the research team catalogued 191 plasma proteins interacting with brain vasculature, finding that 92 actively crossed into the brain parenchyma. Technology Networks reported that researchers labeled mouse blood proteins using Nobel Prize-winning protein-labeling chemistry to track transit without disrupting biology.
“We find the blood-brain barrier is a very dynamic delivery system that seems to connect the brain with the rest of the body to promote brain health,” Haoyue Zhou, PhD, a postdoctoral scholar in Yang's lab and first author of the paper, said.
APOA1 Travels to the Brain to Support Astrocytes
Among the identified proteins, apolipoprotein A1 (APOA1)—predominantly produced in the liver—travels to the brain to support astrocytes, a type of glial cell. Technology Networks explained that this functions like a molecular ZIP code system directing each protein to its destination. Once inside, APOA1 activates pathways that maintain healthy connections between neurons.
Haoyue Zhou, PhD, a postdoctoral scholar in Yang’s lab and first author of the paper, told Technology Networks, “Before the barrier starts leaking harmful proteins into the brain, it stops letting the beneficial ones through.”
Gene Therapy Restores Brain Function
To investigate whether correcting this deficit could alter disease progression, researchers used an adeno-associated virus serotype 8 vector to increase hepatic APOA1 production in 5xFAD mice. NewsBytes reported that boosting APOA1 via gene therapy improved outcomes in mice with Alzheimer’s-like symptoms. Elevated brain APOA1 levels reduced astrocytic lipid accumulation, lowered inflammatory markers such as interleukin-1 beta (IL-1β), and decreased hippocampal dentate gyrus plaque burden.
“The brain's supply line from the body starts to fail,” Zhou said.
Behavioral assessments demonstrated that treated mice exhibited reduced hyperactivity and improved spatial memory in novel-arm preference tests. News-Medical said that while these preclinical findings highlight the liver-plasma-brain APOA1 pathway as a therapeutic target, further investigation is required to determine whether these mechanisms translate to human patients.
| Parameter | Wild-Type Mice | 5xFAD Alzheimer’s Mice | APOA1-Treated 5xFAD Mice |
|---|---|---|---|
| APOA1 Brain Uptake | Normal baseline | Impaired / Reduced | Restored / Elevated |
| Astrocytic Lipids | Baseline levels | Accumulated | Decreased |
| Synaptic Density | Normal baseline | Eroded | Increased in Cortex and Hippocampus |
| Spatial Memory | Normal preference | Impaired | Improved novel-arm preference |
Funding and Research Transparency
References
- Zhou, H., et al. (2026). The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer’s disease models. Cell, DOI: 10.1016/j.cell.2026.10.039
Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
